Concepedia

177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: synthesis and assessment of the ability to target the prostate specific membrane antigen

Tania Hernández-Jiménez, Guillermina Ferro‐Flores, Blanca Ocampo‐García, Enrique Morales-Ávila, Alondra Escudero-Castellanos, Erika Azorín‐Vega, Clara Santos‐Cuevas, Myrna Luna‐Gutiérrez, Nallely Jiménez‐Mancilla, Luis A. Medina,

Journal of Radioanalytical and Nuclear Chemistry · 2018 · 15 citations · 15 references

DOI

Concepts

References

15

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit et al. · International Journal of Cancer · 2014 · 29K citations · Full text

, , +16

German Multicenter Study Investigating<sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil et al. · Journal of Nuclear Medicine · 2016 · 832 citations · Full text

, , +17

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

Martina Benešová, Martin Schäfer, Ulrike Bauder‐Wüst et al. · Journal of Nuclear Medicine · 2015 · 594 citations

, , +17

<sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled PSMA I&amp;T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

Martina Weineisen, Margret Schottelius, Jakub Šimeček et al. · Journal of Nuclear Medicine · 2015 · 532 citations · Full text

, , +17

<sup>177</sup>Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

Richard P. Baum, Harshad Kulkarni, Christiane Schuchardt et al. · Journal of Nuclear Medicine · 2016 · 526 citations · Full text

, , +17